CYP2E1 and central nervous system cancer: CYP2E1 was predictively targeted by has‐miR‐527, which was negatively related to CYP2E1 mRNA expression (p < 0.05), which could explain the possible regulatory mechanism of CYP2E1 down‐regulation in gliomas.